Journal article

MiR-200 can repress breast cancer metastasis through ZEB1-independent but moesin-dependent pathways

X Li, S Roslan, CN Johnstone, JA Wright, CP Bracken, M Anderson, AG Bert, LA Selth, RL Anderson, GJ Goodall, PA Gregory, Y Khew-Goodall

Oncogene | NATURE PUBLISHING GROUP | Published : 2014

Grants

Awarded by National Breast Cancer Foundation of Australia


Awarded by National Health and Medical Research Council of Australia


Awarded by Prostate Cancer Foundation of Australia


Awarded by National Breast Cancer Foundation


Funding Acknowledgements

We thank Professor Joan Massague for providing the MDA-MB-231 LM2 cell line and Dr Ross Dickins for providing the pLMP-puro-GFP construct. We thank Dr Agatha Labrinidis and Ms Yuka Harata-Lee for assistance with bioluminescence imaging and inoculation of tumour cells, respectively, Dr Peter Diamond for help with bone histological analysis and Professors Andreas Evdokiou and Shaun McColl for insightful discussions. This work was supported by fellowships from the National Breast Cancer Foundation of Australia (PAG, CPB and RLA, nos ECF-09-08 and PF-09-03) and grants from the National Health and Medical Research Council of Australia (PAG, YK-G, GJG, RLA and CNJ, nos 566871 and APP1020280), Cancer Council South Australia (GJG, PAG and YK-G) and Prostate Cancer Foundation of Australia (LAS, no. YI 0810).